{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:15:30Z","timestamp":1774977330873,"version":"3.50.1"},"reference-count":134,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mycoplasma genitalium is a fastidious slow-growing bacterium that can be found in the lower urogenital tract of a small percentage of sexually active men and women in the general population. Its carriage in asymptomatic persons, particularly women, contributes to delayed diagnosis, spread of infection, and chronicity in some individuals. Thanks to improved detection methods, there is evidence that M genitalium is an important urogenital pathogen in causing inflammatory disease in men and women, which may have implications in infertility, pregnancy outcomes, and risk for HIV-1 acquisition. As more is learned about M genitalium and its pathogenic potential, laboratory testing to identify people with infections caused by this organism and selection of appropriate treatment regimens become increasingly important. However, these are challenging and complex matters due to the inherent difficulties in its detection in clinical specimens, rapidly escalating antimicrobial resistance, and limited classes of antimicrobial agents that are likely to be effective. The use of nucleic acid amplification tests that have the capability for detecting mutations conferring drug resistance in treatment decisions, referred to as resistance-guided treatment, is now recommended by public health organizations in multiple countries where such testing is available and has the potential to improve treatment outcomes.<\/jats:p>","DOI":"10.1093\/ofid\/ofaf798","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T12:31:30Z","timestamp":1766752290000},"page":"S1367-S1380","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Antimicrobial Susceptibility and Resistance Testing for\n                    <i>Mycoplasma genitalium<\/i>\n                    in Clinical Care"],"prefix":"10.1093","volume":"13","author":[{"given":"Ken B","family":"Waites","sequence":"first","affiliation":[{"name":"Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T Prescott","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Heersink School of Medicine, University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0603-2404","authenticated-orcid":false,"given":"William M","family":"Geisler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"2026033112244234500_ofaf798-B1","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(81)92461-2","article-title":"A newly discovered mycoplasma in the human urogenital tract","volume":"1","author":"Tully","year":"1981","journal-title":"Lancet"},{"key":"2026033112244234500_ofaf798-B2","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/ije\/dyv194","article-title":"Epidemiology of Mycoplasma genitalium in British men and women aged 16\u201344 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)","volume":"44","author":"Sonnenberg","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2026033112244234500_ofaf798-B3","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1097\/OLQ.0000000000001394","article-title":"Prevalence of urogenital Mycoplasma genitalium infection, United States, 2017 to 2018","volume":"48","author":"Torrone","year":"2021","journal-title":"Sex Transm Dis"},{"key":"2026033112244234500_ofaf798-B4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/sextrans-2017-053384","article-title":"Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta-analysis","volume":"94","author":"Baumann","year":"2018","journal-title":"Sex Transm Infect"},{"key":"2026033112244234500_ofaf798-B5","doi-asserted-by":"crossref","first-page":"e0079021","DOI":"10.1128\/jcm.00790-21","article-title":"Latest advances in laboratory detection of Mycoplasma genitalium","volume":"61","author":"Waites","year":"2023","journal-title":"J Clin Microbiol"},{"key":"2026033112244234500_ofaf798-B6","doi-asserted-by":"publisher","DOI":"10.1177\/09564624251359054","article-title":"British association of sexual health and HIV national guideline for the management of infection with Mycoplasma genitalium, 2025","author":"Soni","journal-title":"Int J STD AIDS"},{"key":"2026033112244234500_ofaf798-B7","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1128\/JCM.01053-16","article-title":"Mycoplasma genitalium prevalence, coinfection, and macrolide antibiotic resistance frequency in a multicenter clinical study cohort in the United States","volume":"54","author":"Getman","year":"2016","journal-title":"J Clin Microbiol"},{"key":"2026033112244234500_ofaf798-B8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/CMR.00006-11","article-title":"Mycoplasma genitalium: from chrysalis to multicolored butterfly","volume":"24","author":"Taylor-Robinson","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"2026033112244234500_ofaf798-B9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/sextrans-2023-055935","article-title":"A case of chronic bacterial prostatitis due to Mycoplasma genitalium","volume":"99","author":"Rossotti","year":"2023","journal-title":"Sex Transm Infect"},{"key":"2026033112244234500_ofaf798-B10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.idc.2023.02.009","article-title":"Update in epidemiology and management of Mycoplasma genitalium infections","volume":"37","author":"Wood","year":"2023","journal-title":"Infect Dis Clin North Am"},{"key":"2026033112244234500_ofaf798-B11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/cid\/civ312","article-title":"Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis","volume":"61","author":"Lis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2026033112244234500_ofaf798-B12","first-page":"1878","article-title":"Systematic review and meta-analysis of the association between Mycoplasma genitalium and pelvic inflammatory disease (PID)","volume":"80","author":"Htaik","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026033112244234500_ofaf798-B13","doi-asserted-by":"crossref","first-page":"e220094","DOI":"10.3201\/eid2808.220094","article-title":"Weighing potential benefits and harms of Mycoplasma genitalium testing and treatment approaches","volume":"28","author":"Manhart","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"2026033112244234500_ofaf798-B14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/sextrans-2021-055352","article-title":"Adverse pregnancy and perinatal outcomes associated with Mycoplasma genitalium: systematic review and meta-analysis","volume":"98","author":"Frenzer","year":"2022","journal-title":"Sex Transm Infect"},{"key":"2026033112244234500_ofaf798-B15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/OLQ.0000000000001569","article-title":"Maternal and fetal outcomes in an observational cohort of women with Mycoplasma genitalium infections","volume":"48","author":"Perin","year":"2021","journal-title":"Sex Transm Dis"},{"key":"2026033112244234500_ofaf798-B16","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.medj.2024.05.007","article-title":"Mycoplasma genitalium in pregnancy, including specific co-infections, is associated with lower birthweight: a prospective cohort study","volume":"5","author":"Scoullar","year":"2024","journal-title":"Med"},{"key":"2026033112244234500_ofaf798-B17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/sextrans-2019-054058","article-title":"Extragenital Mycoplasma genitalium infections among men who have sex with men","volume":"96","author":"Latimer","year":"2020","journal-title":"Sex Transm Infect"},{"key":"2026033112244234500_ofaf798-B18","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/BF02111830","article-title":"Mycoplasma genitalium in the joints of two patients with arthritis","volume":"13","author":"Taylor-Robinson","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026033112244234500_ofaf798-B19","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1086\/423809","article-title":"Conjunctivitis associated with Mycoplasma genitalium infection","volume":"39","author":"Bjornelius","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2026033112244234500_ofaf798-B20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/sti.2009.038190","article-title":"The prevalence of urethral and rectal Mycoplasma genitalium and its associations in men who have sex with men attending a genitourinary medicine clinic","volume":"86","author":"Soni","year":"2010","journal-title":"Sex Transm Infect"},{"key":"2026033112244234500_ofaf798-B21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/sti.2010.045138","article-title":"Mycoplasma genitalium is associated with cervicitis and HIV infection in an urban Australian STI clinic population","volume":"87","author":"Lusk","year":"2011","journal-title":"Sex Transm Infect"},{"key":"2026033112244234500_ofaf798-B22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.olq.0000237860.61298.54","article-title":"Mycoplasma genitalium infection and persistence in a cohort of female sex workers in Nairobi, Kenya","volume":"34","author":"Cohen","year":"2007","journal-title":"Sex Transm Dis"},{"key":"2026033112244234500_ofaf798-B23","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/QAD.0b013e328323da3e","article-title":"Association of Mycoplasma genitalium and HIV infection: a systematic review and meta-analysis","volume":"23","author":"Napierala Mavedzenge","year":"2009","journal-title":"AIDS"},{"key":"2026033112244234500_ofaf798-B24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1071\/SH22134","article-title":"Australian sexually transmitted infection (STI) management guidelines for use in primary care 2022 update","volume":"20","author":"Ong","year":"2023","journal-title":"Sex Health"},{"key":"2026033112244234500_ofaf798-B25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/jdv.17972","article-title":"2021 European guideline on the management of Mycoplasma genitalium infections","volume":"36","author":"Jensen","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026033112244234500_ofaf798-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"2026033112244234500_ofaf798-B27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1128\/JCM.02056-06","article-title":"Isolation of Mycoplasma genitalium from first-void urine specimens by coculture with Vero cells","volume":"45","author":"Hamasuna","year":"2007","journal-title":"J Clin Microbiol"},{"key":"2026033112244234500_ofaf798-B28","doi-asserted-by":"crossref","first-page":"002040","DOI":"10.1099\/jmm.0.002040","article-title":"Factors that contribute to the success of primary isolation of Mycoplasma genitalium from clinical samples","volume":"74","author":"Huaman","year":"2025","journal-title":"J Med Microbiol"},{"key":"2026033112244234500_ofaf798-B29","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1093\/infdis\/jix104","article-title":"Mycoplasma genitalium: accurate diagnosis is necessary for adequate treatment","volume":"216","author":"Gaydos","year":"2017","journal-title":"J Infect Dis"},{"key":"2026033112244234500_ofaf798-B30","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s10096-020-04143-9","article-title":"Comparison between Aptima assays (Hologic) and the CoBAS 6800 system (Roche) for the diagnosis of sexually transmitted infections caused by Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium","volume":"40","author":"Barrientos-Duran","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026033112244234500_ofaf798-B31","doi-asserted-by":"crossref","first-page":"e02124-19","DOI":"10.1128\/JCM.02124-19","article-title":"Mycoplasma genitalium detection in urogenital specimens from symptomatic and asymptomatic men and women by use of the cobas TV\/MG test","volume":"58","author":"Van Der Pol","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2026033112244234500_ofaf798-B32","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s10096-020-04135-9","article-title":"Comparison between Abbott m2000 RealTime and Alinity m STI systems for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium","volume":"40","author":"Herrmann","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026033112244234500_ofaf798-B33","doi-asserted-by":"crossref","first-page":"S759","DOI":"10.1093\/cid\/civ771","article-title":"Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines","volume":"61(suppl 8)","author":"Workowski","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2026033112244234500_ofaf798-B34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/cid\/ciu224","article-title":"Diagnostic and resistance testing for Mycoplasma genitalium: what will it take?","volume":"59","author":"Manhart","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2026033112244234500_ofaf798-B35","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1128\/AAC.49.12.4993-4998.2005","article-title":"Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5\u2032 nuclease real-time PCR","volume":"49","author":"Hamasuna","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033112244234500_ofaf798-B36","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1128\/AAC.00724-09","article-title":"Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR","volume":"53","author":"Hamasuna","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033112244234500_ofaf798-B37","doi-asserted-by":"crossref","first-page":"e0365422","DOI":"10.1128\/spectrum.03654-22","article-title":"Omadacycline is highly active in vitro against Mycoplasma genitalium","volume":"10","author":"Waites","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2026033112244234500_ofaf798-B38","doi-asserted-by":"crossref","first-page":"e00698-20","DOI":"10.1128\/AAC.00698-20","article-title":"In vitro activities of eravacycline and other antimicrobial agents against human mycoplasmas and ureaplasmas","volume":"64","author":"Waites","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033112244234500_ofaf798-B39","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1128\/AAC.01956-12","article-title":"Contribution of topoisomerase IV mutation to quinolone resistance in Mycoplasma genitalium","volume":"57","author":"Yamaguchi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033112244234500_ofaf798-B40","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1128\/AAC.36.4.870","article-title":"In vitro susceptibilities of Mycoplasma genitalium to antibiotics","volume":"36","author":"Renaudin","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033112244234500_ofaf798-B41","doi-asserted-by":"crossref","first-page":"e01064-17","DOI":"10.1128\/AAC.01064-17","article-title":"In vitro activities of gepotidacin (GSK2140944) and other antimicrobial agents against human mycoplasmas and ureaplasmas","volume":"61","author":"Waites","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033112244234500_ofaf798-B42","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1099\/00222615-47-12-1115","article-title":"Comparative susceptibilities of various AIDS-associated and human urogenital tract mycoplasmas and strains of Mycoplasma pneumoniae to 10 classes of antimicrobial agent in vitro","volume":"47","author":"Hannan","year":"1998","journal-title":"J Med Microbiol"},{"key":"2026033112244234500_ofaf798-B43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/45.suppl_3.29","article-title":"Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp","volume":"45(suppl 1)","author":"Duffy","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"2026033112244234500_ofaf798-B44","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1128\/AAC.02411-14","article-title":"In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains","volume":"58","author":"Jensen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033112244234500_ofaf798-B45","doi-asserted-by":"crossref","first-page":"e0081921","DOI":"10.1128\/JCM.00819-21","article-title":"Azithromycin and doxycycline resistance profiles of US Mycoplasma genitalium strains and their association with treatment outcomes","volume":"59","author":"Wood","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2026033112244234500_ofaf798-B46","doi-asserted-by":"crossref","first-page":"e0100624","DOI":"10.1128\/aac.01006-24","article-title":"The fungal natural product fusidic acid demonstrates potent activity against Mycoplasma genitalium","volume":"68","author":"Wood","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033112244234500_ofaf798-B47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/sextrans-2024-056338","article-title":"Lefamulin for Mycoplasma genitalium treatment failure in Australia and the USA: a case series and pilot open-label parallel arm randomised trial","volume":"101","author":"Ramchandani","year":"2025","journal-title":"Sex Transm Infect"},{"key":"2026033112244234500_ofaf798-B48","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1080\/22221751.2020.1775498","article-title":"In vitro activity of the first-in-class triazaacenaphthylene gepotidacin alone and in combination with doxycycline against drug-resistant and -susceptible Mycoplasma genitalium","volume":"9","author":"Jensen","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2026033112244234500_ofaf798-B49","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1128\/AAC.04945-14","article-title":"In vitro antibacterial activity of AZD0914 against human mycoplasmas and ureaplasmas","volume":"59","author":"Waites","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033112244234500_ofaf798-B50","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1128\/AAC.00090-09","article-title":"Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101","volume":"53","author":"Waites","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033112244234500_ofaf798-B51","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/jac\/dkae430","article-title":"Phenotypic antibiotic resistance of Mycoplasma genitalium and its variation between different macrolide resistance-associated mutations","volume":"80","author":"Doelman","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"2026033112244234500_ofaf798-B52","doi-asserted-by":"crossref","first-page":"e02380-17","DOI":"10.1128\/AAC.02380-17","article-title":"In vitro activity of lefamulin against sexually transmitted bacterial pathogens","volume":"62","author":"Paukner","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033112244234500_ofaf798-B53","doi-asserted-by":"crossref","first-page":"e0134624","DOI":"10.1128\/aac.01346-24","article-title":"In vitro test of the novel antibiotic lefamulin alone and in combination with doxycycline against Mycoplasma genitalium","volume":"69","author":"Salado-Rasmussen","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033112244234500_ofaf798-B54","doi-asserted-by":"crossref","first-page":"S802","DOI":"10.1093\/cid\/civ785","article-title":"Efficacy of antimicrobial therapy for Mycoplasma genitalium infections","volume":"61(suppl 8)","author":"Manhart","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2026033112244234500_ofaf798-B55","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1093\/infdis\/jix132","article-title":"New horizons in Mycoplasma genitalium treatment","volume":"216","author":"Bradshaw","year":"2017","journal-title":"J Infect Dis"},{"key":"2026033112244234500_ofaf798-B56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jiac.2014.08.021","article-title":"Sitafloxacin: antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV","volume":"21","author":"Deguchi","year":"2015","journal-title":"J Infect Chemother"},{"key":"2026033112244234500_ofaf798-B57","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/jac\/dky022","article-title":"In vitro activity of zoliflodacin (ETX0914) against macrolide-resistant, fluoroquinolone-resistant and antimicrobial-susceptible Mycoplasma genitalium strains","volume":"73","author":"Damiao Gouveia","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2026033112244234500_ofaf798-B58","doi-asserted-by":"crossref","first-page":"e0000623","DOI":"10.1128\/aac.00006-23","article-title":". In vitro susceptibility and resistance of Mycoplasma genitalium to nitroimidazoles","volume":"67","author":"Wood","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033112244234500_ofaf798-B59","doi-asserted-by":"crossref","first-page":"e0024322","DOI":"10.1128\/aac.00243-22","article-title":"Impact of 16S rRNA single nucleotide polymorphisms on Mycoplasma genitalium organism load with doxycycline treatment","volume":"66","author":"Chua","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033112244234500_ofaf798-B60","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/jac\/dkab016","article-title":"Identification of 16S rRNA mutations in Mycoplasma genitalium potentially associated with tetracycline resistance in vivo but not selected in vitro in M genitalium and Chlamydia trachomatis","volume":"76","author":"Le Roy","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2026033112244234500_ofaf798-B61","doi-asserted-by":"crossref","first-page":"e2127","DOI":"10.1093\/cid\/ciaa1832","article-title":"High prevalence and high rate of antibiotic resistance of Mycoplasma genitalium infections in men who have sex with men: a substudy of the ANRS IPERGAY pre-exposure prophylaxis trial","volume":"73","author":"Bercot","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026033112244234500_ofaf798-B62","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/0956462418816757","article-title":"Two cases of multidrug-resistant genitourinary Mycoplasma genitalium infection successfully eradicated with minocycline","volume":"30","author":"Glaser","year":"2019","journal-title":"Int J STD AIDS"},{"key":"2026033112244234500_ofaf798-B63","doi-asserted-by":"crossref","first-page":"ofad427","DOI":"10.1093\/ofid\/ofad427","article-title":"Efficacy of minocycline for the treatment of Mycoplasma genitalium","volume":"10","author":"Clarke","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026033112244234500_ofaf798-B64","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/iju.70046","article-title":"Outcomes of sequential therapy with minocycline and sitafloxacin versus sitafloxacin monotherapy for Mycoplasma genitalium infections","volume":"32","author":"Kobori","year":"2025","journal-title":"Int J Urol"},{"key":"2026033112244234500_ofaf798-B65","doi-asserted-by":"crossref","first-page":"101047","DOI":"10.1016\/j.lanmic.2024.101047","article-title":"Evolving patterns of macrolide and fluoroquinolone resistance in Mycoplasma genitalium: an updated systematic review and meta-analysis","volume":"6","author":"Chua","year":"2025","journal-title":"Lancet Microbe"},{"key":"2026033112244234500_ofaf798-B66","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/0956462413502008","article-title":"Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance","volume":"24","author":"Couldwell","year":"2013","journal-title":"Int J STD AIDS"},{"key":"2026033112244234500_ofaf798-B67","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/cid\/ciab1058","article-title":"Combination therapy for Mycoplasma genitalium, and new insights into the utility of parC mutant detection to improve cure","volume":"75","author":"Vodstrcil","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026033112244234500_ofaf798-B68","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/cid\/ciad057","article-title":"gyrA mutations in Mycoplasma genitalium and their contribution to moxifloxacin failure: time for the next generation of resistance-guided therapy","volume":"76","author":"Murray","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026033112244234500_ofaf798-B69","first-page":"1017","article-title":"Moxifloxacin and sitafloxacin treatment failure in Mycoplasma genitalium infection: association with parC mutation G248T (S83I) and concurrent gyrA mutations","volume":"221","author":"Murray","year":"2020","journal-title":"J Infect Dis"},{"key":"2026033112244234500_ofaf798-B70","doi-asserted-by":"crossref","first-page":"e0027822","DOI":"10.1128\/aac.00278-22","article-title":"Parc variants in Mycoplasma genitalium: trends over time and association with moxifloxacin failure","volume":"66","author":"Murray","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033112244234500_ofaf798-B71","doi-asserted-by":"crossref","first-page":"e3618","DOI":"10.1371\/journal.pone.0003618","article-title":"Persistence of Mycoplasma genitalium following azithromycin therapy","volume":"3","author":"Bradshaw","year":"2008","journal-title":"PLoS One"},{"key":"2026033112244234500_ofaf798-B72","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/OLQ.0000000000001493","article-title":"Frequency and correlates of Mycoplasma genitalium antimicrobial resistance mutations and their association with treatment outcomes: findings from a national sentinel surveillance pilot in England","volume":"48","author":"Fifer","year":"2021","journal-title":"Sex Transm Dis"},{"key":"2026033112244234500_ofaf798-B73","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/OLQ.0000000000001009","article-title":"Men who have sex with men with Mycoplasma genitalium\u2013positive nongonococcal urethritis are more likely to have macrolide-resistant strains than men with only female partners: a prospective study","volume":"46","author":"McIver","year":"2019","journal-title":"Sex Transm Dis"},{"key":"2026033112244234500_ofaf798-B74","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/cid\/ciad405","article-title":"Mycoplasma genitalium in the US (MyGeniUS): surveillance data from sexual health clinics in 4 US regions","volume":"77","author":"Manhart","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026033112244234500_ofaf798-B75","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/09564624211070704","article-title":"Worryingly high prevalence of resistance-associated mutations to macrolides and fluoroquinolones in Mycoplasma genitalium among men who have sex with men with recurrent sexually transmitted infections","volume":"33","author":"De Baetselier","year":"2022","journal-title":"Int J STD AIDS"},{"key":"2026033112244234500_ofaf798-B76","doi-asserted-by":"crossref","first-page":"1130762","DOI":"10.3389\/fmicb.2023.1130762","article-title":"Mycoplasma genitalium prevalence, antimicrobial resistance-associated mutations, and coinfections with non-viral sexually transmitted infections in high-risk populations in Guatemala, Malta, Morocco, Peru and South Africa, 2019\u20132021","volume":"14","author":"Shipitsyna","year":"2023","journal-title":"Front Microbiol"},{"key":"2026033112244234500_ofaf798-B77","doi-asserted-by":"crossref","first-page":"001429","DOI":"10.1099\/jmm.0.001429","article-title":"Prevalence of Mycoplasma genitalium fluoroquinolone-resistance markers, and dual-class-resistance markers, in asymptomatic men who have sex with men","volume":"70","author":"Chua","year":"2021","journal-title":"J Med Microbiol"},{"key":"2026033112244234500_ofaf798-B78","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12879-015-0781-7","article-title":"Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin","volume":"15","author":"Guschin","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2026033112244234500_ofaf798-B79","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3201\/eid2402.170902","article-title":"Use of pristinamycin for macrolide-resistant Mycoplasma genitalium infection","volume":"24","author":"Read","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2026033112244234500_ofaf798-B80","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1097\/OLQ.0000000000001415","article-title":"Initial failure of pristinamycin treatment in a case of multidrug-resistant Mycoplasma genitalium urethritis eventually treated by sequential therapy","volume":"48","author":"Palich","year":"2021","journal-title":"Sex Transm Dis"},{"key":"2026033112244234500_ofaf798-B81","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/dkae403","article-title":"Prolonged sitafloxacin and doxycycline combination regimen for treating infections by highly resistant Mycoplasma genitalium","volume":"80","author":"Ando","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"2026033112244234500_ofaf798-B82","doi-asserted-by":"crossref","first-page":"ofad590","DOI":"10.1093\/ofid\/ofad590","article-title":"Efficacy of sitafloxacin for Mycoplasma genitalium in an era of increasing antimicrobial resistance","volume":"10","author":"Samra","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026033112244234500_ofaf798-B83","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/OLQ.0000000000002105","article-title":"Efficacy of doxycycline-sitafloxacin sequential therapy for urogenital Mycoplasma genitalium infection in Nanjing, China","volume":"52","author":"Yuan","year":"2025","journal-title":"Sex Transm Dis"},{"key":"2026033112244234500_ofaf798-B84","doi-asserted-by":"crossref","first-page":"e52565","DOI":"10.2196\/52565","article-title":"Sitafloxacin- versus moxifloxacin-based sequential treatment for Mycoplasma genitalium infections: protocol for a multicenter, open-label randomized controlled trial","volume":"12","author":"Ando","year":"2023","journal-title":"JMIR Res Protoc"},{"key":"2026033112244234500_ofaf798-B85","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/jac\/dkad208","article-title":"Effectiveness of sitafloxacin monotherapy for quinolone-resistant rectal and urogenital Mycoplasma genitalium infections: a prospective cohort study","volume":"78","author":"Ando","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"2026033112244234500_ofaf798-B86","first-page":"208","article-title":"Novel use of oral chloramphenicol for treatment-resistant Mycoplasma genitalium","volume":"99","author":"Goodfellow","year":"2023","journal-title":"Sex Transm Infect"},{"key":"2026033112244234500_ofaf798-B87","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00007435-198410001-00042","article-title":"Clinical evaluation of thiamphenicol in treatment of nongonococcal urethritis","volume":"11","author":"Saito","year":"1984","journal-title":"Sex Transm Dis"},{"key":"2026033112244234500_ofaf798-B88","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00007435-198410001-00039","article-title":"Acute salpingitis and thiamphenicol: a microbiologic and therapeutic study","volume":"11","author":"Kunz","year":"1984","journal-title":"Sex Transm Dis"},{"key":"2026033112244234500_ofaf798-B89","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1093\/jac\/dkaf272","article-title":"In vitro activity of thiamphenicol against drug-susceptible and drug-resistant strains of Mycoplasma genitalium","volume":"80","author":"Skovmand","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"2026033112244234500_ofaf798-B90","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/jac\/dkw405","article-title":"Successful outcome of macrolide-resistant Mycoplasma genitalium urethritis after spectinomycin treatment: a case report","volume":"72","author":"Falk","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2026033112244234500_ofaf798-B91","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1097\/OLQ.0000000000002101","article-title":"Successful treatment of Mycoplasma genitalium urethritis with high-dose tinidazole","volume":"52","author":"Liscynesky","year":"2025","journal-title":"Sex Transm Dis"},{"key":"2026033112244234500_ofaf798-B92","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/cid\/ciaa101","article-title":"A randomized controlled trial of ceftriaxone and doxycycline, with or without metronidazole, for the treatment of acute pelvic inflammatory disease","volume":"72","author":"Wiesenfeld","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026033112244234500_ofaf798-B93","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2025-056517","article-title":"Combination therapy for multidrug-resistant Mycoplasma genitalium infections: a case series","author":"Vanbaelen","journal-title":"Sex Transm Infect"},{"key":"2026033112244234500_ofaf798-B94","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/venereology4030010","article-title":"Piercing through: lefamulin treatment of an antibiotic-resistant Mycoplasma genitalium urethritis","volume":"4","author":"Yuchi","year":"2025","journal-title":"Venereology"},{"key":"2026033112244234500_ofaf798-B95","volume-title":"CLSI M43-A: methods for antimicrobial susceptibility testing of human mycoplasmas; approved guideline","author":"Clinical Laboratory Standards Institute","year":"2011"},{"key":"2026033112244234500_ofaf798-B96","doi-asserted-by":"crossref","first-page":"e0384523","DOI":"10.1128\/spectrum.03845-23","article-title":"Detection of resistance to macrolides and fluoroquinolones in Mycoplasma genitalium by targeted next-generation sequencing","volume":"12","author":"Chiribau","year":"2024","journal-title":"Microbiol Spectr"},{"key":"2026033112244234500_ofaf798-B97","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/cid\/ciu217","article-title":"Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey","volume":"59","author":"Salado-Rasmussen","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2026033112244234500_ofaf798-B98","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/JCM.03318-13","article-title":"Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis","volume":"52","author":"Touati","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2026033112244234500_ofaf798-B99","doi-asserted-by":"crossref","first-page":"e35593","DOI":"10.1371\/journal.pone.0035593","article-title":"Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis","volume":"7","author":"Twin","year":"2012","journal-title":"PLoS One"},{"key":"2026033112244234500_ofaf798-B100","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/jdv.12963","article-title":"Identification of macrolide-resistant Mycoplasma genitalium using real-time PCR","volume":"29","author":"Wold","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026033112244234500_ofaf798-B101","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1128\/JCM.02312-16","article-title":"Prospective evaluation of ResistancePlus MG, a new Multiplex quantitative PCR assay for detection of Mycoplasma genitalium and macrolide resistance","volume":"55","author":"Tabrizi","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2026033112244234500_ofaf798-B102","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-1-61779-937-2_8","article-title":"Protocol for the detection of Mycoplasma genitalium by PCR from clinical specimens and subsequent detection of macrolide resistance-mediating mutations in region V of the 23S rRNA gene","volume":"903","author":"Jensen","year":"2012","journal-title":"Methods Mol Biol"},{"key":"2026033112244234500_ofaf798-B103","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1128\/JCM.00012-16","article-title":"A 5","volume":"54","author":"Kristiansen","year":"2016","journal-title":"J Clin Microbiol"},{"key":"2026033112244234500_ofaf798-B104","doi-asserted-by":"crossref","first-page":"e0101422","DOI":"10.1128\/spectrum.01014-22","article-title":"Rapid detection of antimicrobial resistance in Mycoplasma genitalium by high-resolution melting analysis with unlabeled probes","volume":"10","author":"Li","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2026033112244234500_ofaf798-B105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.diagmicrobio.2018.02.002","article-title":"Evaluation of a real-time PCR assay for detection of Mycoplasma genitalium and macrolide resistance-mediating mutations from clinical specimens","volume":"91","author":"Xiao","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026033112244234500_ofaf798-B106","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/OLQ.0000000000001226","article-title":"Comparison of assays for the diagnosis of Mycoplasma genitalium and macrolide resistance mutations in self-collected vaginal swabs and urine","volume":"47","author":"Chernesky","year":"2020","journal-title":"Sex Transm Dis"},{"key":"2026033112244234500_ofaf798-B107","doi-asserted-by":"crossref","first-page":"e01478-19","DOI":"10.1128\/JCM.01478-19","article-title":"Clinical evaluation of three commercial PCR assays for the detection of macrolide resistance in Mycoplasma genitalium","volume":"58","author":"Le Roy","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2026033112244234500_ofaf798-B108","first-page":"73","article-title":"Evaluation of 5 commercial assays for the detection of Mycoplasma genitalium and other urogenital mycoplasmas","volume":"210","author":"Naidu","year":"2021","journal-title":"Med Microbiol Immunol"},{"key":"2026033112244234500_ofaf798-B109","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/sextrans-2017-053366","article-title":"Evaluation of the Mycoplasma genitalium resistance plus kit for the detection of M genitalium and mutations associated with macrolide resistance","volume":"94","author":"Pitt","year":"2018","journal-title":"Sex Transm Infect"},{"key":"2026033112244234500_ofaf798-B110","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s10096-021-04170-0","article-title":"Clinical evaluation of commercial PCR assays for antimicrobal resistance in Mycoplasma genitalium and estimation of resistance-mediated mutation prevalence in Moscow and Moscow region","volume":"40","author":"Shedko","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026033112244234500_ofaf798-B111","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1128\/JCM.02168-16","article-title":"Evaluation of a commercial multiplex quantitative PCR (qPCR) assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance-associated mutations in clinical specimens","volume":"55","author":"Le Roy","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2026033112244234500_ofaf798-B112","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1099\/jmm.0.001140","article-title":"Performance of the ResistancePlus MG diagnostic test for Mycoplasma genitalium using samples collected with Hologic Aptima Specimen Collection kits","volume":"69","author":"Murray","year":"2020","journal-title":"J Med Microbiol"},{"key":"2026033112244234500_ofaf798-B113","doi-asserted-by":"crossref","first-page":"115349","DOI":"10.1016\/j.diagmicrobio.2021.115349","article-title":"Comparison of three real-time PCR methods for detection of macrolide-resistant Mycoplasma genitalium in Sweden","volume":"100","author":"Gullsby","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026033112244234500_ofaf798-B114","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.3390\/ijms24087218","article-title":"Retrospective and comparative study of three molecular assays for the macrolide resistance detection in Mycoplasma genitalium positive urogenital specimens","volume":"24","author":"Peris","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026033112244234500_ofaf798-B115","doi-asserted-by":"crossref","first-page":"e01245-17","DOI":"10.1128\/JCM.01245-17","article-title":"Evaluation of the SpeeDx ResistancePlus MG diagnostic test for Mycoplasma genitalium on the Applied Biosystems 7500 Fast quantitative PCR platform","volume":"56","author":"Su","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2026033112244234500_ofaf798-B116","doi-asserted-by":"crossref","first-page":"ovad124","DOI":"10.1093\/lambio\/ovad124","article-title":"Evaluation of TIB Molbiol LightMix assays for detection of Mycoplasma genitalium and key resistance mutations for macrolides and fluoroquinolones","volume":"76","author":"Balgovind","year":"2023","journal-title":"Lett Appl Microbiol"},{"key":"2026033112244234500_ofaf798-B117","doi-asserted-by":"crossref","first-page":"e01900-19","DOI":"10.1128\/JCM.01900-19","article-title":"Evaluation of the ResistancePlus MG FleXible assay for detection of wild-type and 23S rRNA-mutated Mycoplasma genitalium strains","volume":"58","author":"Drud","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2026033112244234500_ofaf798-B118","doi-asserted-by":"crossref","first-page":"e01897","DOI":"10.1128\/JCM.01897-19","article-title":"Evaluation of the ResistancePlus MG FleXible cartridge for near-point-of-care testing of Mycoplasma genitalium and associated macrolide resistance mutations","volume":"58","author":"Sweeney","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2026033112244234500_ofaf798-B119","doi-asserted-by":"crossref","first-page":"115062","DOI":"10.1016\/j.diagmicrobio.2020.115062","article-title":"Clinical evaluation of the ResistancePlus MG FleXible test on the GeneXpert Infinity-48s instrument: a near-patient assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance","volume":"97","author":"Fernandez-Huerta","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"2026033112244234500_ofaf798-B120","doi-asserted-by":"publisher","first-page":"0.001271","DOI":"10.1099\/jmm.0.001271","article-title":"Evaluation of ResistancePlus MG FleXible, a \u201cnear-patient\u201d test for the detection of Mycoplasma genitalium and macrolide resistance mutations, using freshly collected clinical samples","volume":"70","author":"Murray","year":"2021","journal-title":"J Med Microbiol"},{"key":"2026033112244234500_ofaf798-B121","doi-asserted-by":"crossref","first-page":"e00020-21","DOI":"10.1128\/JCM.00020-21","article-title":"Performance of three commercial molecular diagnostic assays for the simultaneous detection of Mycoplasma genitalium and macrolide resistance","volume":"59","author":"Le Roy","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2026033112244234500_ofaf798-B122","doi-asserted-by":"crossref","first-page":"e0113522","DOI":"10.1128\/jcm.01135-22","article-title":"Clinical performance of three commercial molecular diagnostic assays for the detection of fluoroquinolone resistance-associated mutations in Mycoplasma genitalium","volume":"60","author":"Gardette","year":"2022","journal-title":"J Clin Microbiol"},{"key":"2026033112244234500_ofaf798-B123","first-page":"191","article-title":"Performance of the first commercial dual resistance assay, AmpliSens Mycoplasma genitalium-ML\/FQ-Resist-FL, for detection of potential macrolide and quinolone resistance-associated mutations and prevalence of M genitalium resistance mutations in St Petersburg, Russia","volume":"99","author":"Shipitsyna","year":"2023","journal-title":"Sex Transm Infect"},{"key":"2026033112244234500_ofaf798-B124","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/cid\/ciy477","article-title":"Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation","volume":"68","author":"Read","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026033112244234500_ofaf798-B125","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/cid\/ciz1031","article-title":"Resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability","volume":"71","author":"Durukan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026033112244234500_ofaf798-B126","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/0956462420987764","article-title":"Resistance-guided treatment of Mycoplasma genitalium infection at a UK sexual health centre","volume":"32","author":"Conway","year":"2021","journal-title":"Int J STD AIDS"},{"key":"2026033112244234500_ofaf798-B127","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.3390\/diagnostics14232665","article-title":"Implementation of Mycoplasma genitalium diagnostics with macrolide-resistance detection improves patient treatment outcomes in Bulgaria","volume":"14","author":"Philipova","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"2026033112244234500_ofaf798-B128","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/OLQ.0000000000001132","article-title":"Quinolone resistance-associated mutations in Mycoplasma genitalium: not ready for prime time","volume":"47","author":"Manhart","year":"2020","journal-title":"Sex Transm Dis"},{"key":"2026033112244234500_ofaf798-B129","doi-asserted-by":"crossref","first-page":"106089","DOI":"10.1016\/j.mimet.2020.106089","article-title":"A custom amplicon sequencing approach to detect resistance associated mutations and sequence types in Mycoplasma genitalium","volume":"179","author":"Plummer","year":"2020","journal-title":"J Microbiol Methods"},{"key":"2026033112244234500_ofaf798-B130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/sextrans-2023-056093","article-title":"Mycoplasma genitalium treatment outcomes among a cohort failing macrolide resistance-guided treatment across three London sexual health clinics","volume":"101","author":"Johnson","year":"2025","journal-title":"Sex Transm Infect"},{"key":"2026033112244234500_ofaf798-B131","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1071\/SH22012","article-title":"Mycoplasma genitalium: enhanced management using expanded resistance-guided treatment strategies","volume":"19","author":"Sweeney","year":"2022","journal-title":"Sex Health"},{"key":"2026033112244234500_ofaf798-B132","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/S1473-3099(21)00629-0","article-title":"Individualised treatment of Mycoplasma genitalium infection-incorporation of fluoroquinolone resistance testing into clinical care","volume":"22","author":"Sweeney","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2026033112244234500_ofaf798-B133","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/jac\/dkad373","article-title":"Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, Australia","volume":"79","author":"Ertl","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"2026033112244234500_ofaf798-B134","doi-asserted-by":"crossref","first-page":"12856","DOI":"10.1038\/s41598-024-63056-1","article-title":"Cost-effectiveness of resistance-guided therapy for Mycoplasma genitalium in Australia","volume":"14","author":"Adawiyah","year":"2024","journal-title":"Sci Rep"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/Supplement_2\/S1367\/67659122\/ofaf798.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/Supplement_2\/S1367\/67659122\/ofaf798.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:25:02Z","timestamp":1774974302000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/13\/Supplement_2\/S1367\/8559646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":134,"journal-issue":{"issue":"Supplement_2","published-print":{"date-parts":[[2026,3,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf798","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,30]]}}}